Seventure

ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate
21 January 2026

ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate

ErVimmune, a biotechnology company developing next-generation therapeutic vaccines targeting new families of ‘unconventional’ tumor antigens derived from human endogenous...

Read more
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis
20 January 2026

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in...

Read more
The Sanctuary Group raises €5 million to roll out its sports studios across France
12 January 2026

The Sanctuary Group raises €5 million to roll out its sports studios across France

Specializing in fitness studios, French startup The Sanctuary Group has announced that it has raised €4.7 million in funding. This will enable it to accelerate the rollout of...

Read more
SkillCorner Secures $60M Growth Investment to Accelerate Global Sports Data Innovation
17 December 2025

SkillCorner Secures $60M Growth Investment to Accelerate Global Sports Data Innovation

SkillCorner is pleased to announce a $60 million growth investment from Silversmith Capital Partners, marking an important step forward in our mission to deliver world-leading...

Read more
MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival
8 December 2025

MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
14 November 2025

MaaT Pharma announces the successful completion of its Global Offering of €9.1 million

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
Sunrise Group: $29 Million Raised For Expanding Dreem Health
1 October 2025

Sunrise Group: $29 Million Raised For Expanding Dreem Health

Sunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep...

Read more
With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.
22 September 2025

With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.

Kapsera, a pioneer in sustainable microencapsulation for the agri-food industry, announces the entry of Seventure Partners into its capital as part of its Series A financing...

Read more
MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe
2 July 2025

MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
The top 50 venture investors in France : Seventure ranked as #7
13 June 2025

The top 50 venture investors in France : Seventure ranked as #7

We mined CB Insights data on top France-based firms to rank them based on their portfolio strength and ability to predict future winners.

Read more